Pediatr Infect Dis J. 2018 Mar;37(3):e72-e78. doi: 10.1097/INF.0000000000001862.
To re-evaluate antibiotic strategies for acute otitis media (AOM) in young children, we analyzed the trends of nasopharyngeal carriage and antibiotic resistance of Streptococcus pneumoniae (Sp), Haemophilus influenzae (Hi) and Moraxella catarrhalis (Mc) isolated from young children with AOM during a 16-year period.
This cross-sectional study analyzed from 2001 to 2016 the nasopharyngeal carriage of Sp, Hi and Mc of young children with AOM. Medical history and physical findings were reported. Periods were defined by pneumococcal conjugate vaccine (PCV) introduction. We separately analyzed the 13-valent PCV (PCV13) period, which started after 2013.
During the study, 12,973 children with AOM were enrolled by 138 pediatricians. By comparing the first and last PCV periods, the proportion of children in day care centers and that of AOM with conjunctivitis significantly increased. The proportion of penicillin nonsusceptible Sp carriage significantly decreased during the study, with 0.8% of penicillin-resistant strains isolated in the PCV13 period, but that of β-lactamase-producing Hi continually increased to 23.6% in 2016. The level of Mc β-lactamase-producing strains remained high (>97%). In the PCV13 period, the main predictors of β-lactamase-producing Hi carriage were conjunctivitis (adjusted odds ratio = 6.0, 95% confidence interval [4.7-7.7]) and attending a day care center (2.4 [1.7-3.5]).
In the PCV13 period, the proportion of penicillin-resistant Sp carriage was very low and that of β-lactamase-producing Hi carriage did not exceed 20% among children with AOM and without conjunctivitis. Our results suggest that amoxicillin may remain the first-line antibiotic treatment for AOM in young children except for those with conjunctivitis, for which amoxicillin-clavulanate is still the best antibiotic.
为了重新评估儿童急性中耳炎(AOM)的抗生素策略,我们分析了在 16 年间,从患有 AOM 的儿童中分离出的肺炎链球菌(Sp)、流感嗜血杆菌(Hi)和卡他莫拉菌(Mc)的鼻咽携带率和抗生素耐药性趋势。
这项横断面研究分析了 2001 年至 2016 年间患有 AOM 的儿童的 Sp、Hi 和 Mc 鼻咽携带情况。报告了病史和体格检查结果。研究期间通过肺炎球菌结合疫苗(PCV)的引入进行了定义。我们分别分析了 2013 年后开始的 13 价 PCV(PCV13)时期。
在研究期间,通过 138 名儿科医生共纳入了 12973 名患有 AOM 的儿童。通过比较第一和最后一个 PCV 时期,日托中心儿童和伴有结膜炎的 AOM 儿童的比例显著增加。研究期间,青霉素不敏感 Sp 携带率显著下降,在 PCV13 时期分离出 0.8%的青霉素耐药株,但产β-内酰胺酶的 Hi 持续增加,2016 年达到 23.6%。Mc 产β-内酰胺酶株的水平仍然很高(>97%)。在 PCV13 时期,产β-内酰胺酶的 Hi 携带的主要预测因素是结膜炎(调整后的优势比=6.0,95%置信区间[4.7-7.7])和入托(2.4[1.7-3.5])。
在 PCV13 时期,青霉素耐药 Sp 携带率非常低,且无结膜炎的 AOM 儿童中,产β-内酰胺酶的 Hi 携带率未超过 20%。我们的研究结果表明,除了结膜炎患儿外,阿莫西林仍可作为儿童 AOM 的一线抗生素治疗药物,对于结膜炎患儿,阿莫西林-克拉维酸仍然是最佳抗生素。